W. B. Van Den Berg

3.2k citations

42 papers · 2.6k indexed · 1 hit paper · h-index 20

Rheumatology top 0.5%
Molecular Biology top 10%
Pharmacology top 2%
Immunology top 10%
Surgery top 10%

Co-authors: M.G. Chambers Christopher B. Little S.S. Glasson P.M. van der Kraan E.L. Vitters Leo A. B. Joosten Fons A. J. van de Loo M.M. Helsen
Topics: Osteoarthritis Treatment and Mechanisms (17 papers)Cell Adhesion Molecules Research (8 papers)Cytokine Signaling Pathways and Interactions (7 papers)
Cited by: Rheumatology Immunology and Allergy Pharmacology
Journals: Journal of Clinical Investigation The Journal of Immunology Annals of the Rheumatic Diseases
Partner nations: Netherlands United States Germany

In The Last Decade

W. B. Van Den Berg

42 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mouse

2010 1.3k citations S.S. Glasson, M.G. Chambers et al. Osteoarthritis and Cartilage profile →

Peers

Countries citing papers authored by W. B. Van Den Berg

Since Specialization

Citations

This map shows the geographic impact of W. B. Van Den Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. B. Van Den Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. B. Van Den Berg more than expected).

Fields of papers citing papers by W. B. Van Den Berg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. B. Van Den Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. B. Van Den Berg. The network helps show where W. B. Van Den Berg may publish in the future.

Co-authorship network of co-authors of W. B. Van Den Berg

This figure shows the co-authorship network connecting the top 25 collaborators of W. B. Van Den Berg. A scholar is included among the top collaborators of W. B. Van Den Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. B. Van Den Berg. W. B. Van Den Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mousebreakdown → 2010 ·Osteoarthritis and Cartilage ·S.S. Glasson,M.G. Chambers,W. B. Van Den Berg,Christopher B. Little	1292
2	IL-32γ and Streptococcus pyogenes cell wall fragments synergise for IL-1-dependent destructive arthritis via upregulation of TLR-2 and NOD2 2010 ·Annals of the Rheumatic Diseases ·Bas Heinhuis,Marije I. Koenders,F.A. van de Loo,Peter L. E. M. van Lent,(unknown),C A Dinarello,Lieke Joosten,W. B. Van Den Berg	28
3	Alpha-fodrin as a putative autoantigen in Graves’ ophthalmopathy 2005 ·Clinical & Experimental Immunology ·George J. Kahaly,Holger Bang,W. B. Van Den Berg,Manuela Dittmar	17
4	Loss of transforming growth factor counteraction on interleukin 1 mediated effects in cartilage of old mice 2002 ·Annals of the Rheumatic Diseases ·Alwin Scharstuhl,Henk M. van Beuningen,E.L. Vitters,P.M. van der Kraan,W. B. Van Den Berg	53
5	Neurovascular plasticity in the knee joint of an arthritic mouse model 2000 ·The Anatomical Record ·(unknown),(unknown),W. B. Van Den Berg,(unknown)	2
6	Anabolic and destructive mediators in osteoarthritis 2000 ·Current Opinion in Clinical Nutrition & Metabolic Care ·P.M. van der Kraan,W. B. Van Den Berg	92
7	Differential effects of IGF-1 ans TGFβ-2 on the assembly of proteoglycans in pericellular and territorial matrix by cultured bovine articular chondrocytes 1998 ·Osteoarthritis and Cartilage ·Gerjo J. V. M. van Osch,W. B. Van Den Berg,Ernst B. Hunziker,(unknown)	98
8	Interleukin-1 receptor antagonist prevents expression of the metalloproteinase-generated neoepitope VDIPEN in antigen-induced arthritis 1998 ·Arthritis & Rheumatism ·Joyce B. J. van Meurs,Peter L. E. M. van Lent,Irwin Singer,E K Bayne,Fons A. J. van de Loo,W. B. Van Den Berg	52
9	Dual role of IL-12 in early and late stages of murine collagen type II arthritis 1997 ·The Journal of Immunology ·Leo A. B. Joosten,Erik Lubberts,M.M. Helsen,W. B. Van Den Berg	119
10	Localization and quantification of the insulin-like growth factor-1 receptor in mouse articular cartilage by confocal laser scanning microscopy. 1994 ·Journal of Histochemistry & Cytochemistry ·Pernette J. Verschure,Jan van Marle,Leo A. B. Joosten,W. B. Van Den Berg	17
11	Role of phagocytic synovial lining cells in experimental arthritis 1993 ·Inflammation Research ·Peter L. E. M. van Lent,A. Hoek,Liduine A. van den Bersselaar,Nico van Rooijen,W. B. Van Den Berg	8
12	Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis. 1992 ·PubMed ·Fons A. J. van de Loo,Onno J. Arntz,Ivan G. Otterness,W. B. Van Den Berg	82
13	Streptococcal cell wall-induced arthritis and adjuvant arthritis in F344 → lewis and in Lewis → F344 bone marrow chimeras 1991 ·Cellular Immunology ·(unknown),Maries van den Broek,W. B. Van Den Berg	7
14	In Vivo Evidence for a Key Role of Il-1 in Cartilage Destruction in Experimental Arthritis 1991 ·Birkhäuser Basel eBooks ·W. B. Van Den Berg,F.A. van de Loo,Ivan G. Otterness,Onno J. Arntz,Leo A. B. Joosten	26
15	Decrease of inorganic blood sulfate following treatment with selected antirheumatic drugs: Potential consequence for articular cartilage 1990 ·Inflammation Research ·(unknown),P.M. van der Kraan,W. B. Van Den Berg	8
16	Protective effect of rimexolone on cartilage damage in arthritic mice: A comparative study with triamcinolone hexacetonide 1990 ·Inflammation Research ·Lieke Joosten,M.M. Helsen,W. B. Van Den Berg	10
17	Immune complex formation between IgM rheumatoid factor and IgG generated by hyaluronic acid 1989 ·Arthritis & Rheumatism ·P. Faaber,L. A. M. Van Den Bersselaar,L.B.A. van de Putte,W. B. Van Den Berg	6
18	Fate of antigen after intravenous and intraarticular injection into mice. Role of molecular weight and charge. 1989 ·PubMed ·Peter L. E. M. van Lent,Liduine van den Bersselaar,(unknown),W. B. Van Den Berg	14
19	Crohn's disease associated with arthritis: a possible role for cross‐reactivity between gut pathogenesis of arthritis 1988 ·Arthritis & Rheumatism ·Maries van den Broek,(unknown),W. B. Van Den Berg	18
20	Flare-up of antigen-induced arthritis in mice after challenge with oral antigen. 1984 ·PubMed ·Jan Willem Lens,W. B. Van Den Berg,L. B. A. van de Putte,Liduine van den Bersselaar	25

About W. B. Van Den Berg

W. B. Van Den Berg is a scholar working on Rheumatology, Immunology and Allergy and Immunology, having authored 42 papers that have together received 2.6k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (17 papers), Cell Adhesion Molecules Research (8 papers) and Cytokine Signaling Pathways and Interactions (7 papers). The work is most often cited by research in Rheumatology (1.7k citations), Immunology and Allergy (245 citations) and Pharmacology (517 citations). W. B. Van Den Berg has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include M.G. Chambers, Christopher B. Little, S.S. Glasson, P.M. van der Kraan, E.L. Vitters, Leo A. B. Joosten, Fons A. J. van de Loo, M.M. Helsen, Erik Lubberts and Henk M. van Beuningen. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Immunology and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact